Management is buying the same thing twice: proven demand from one place is being replicated into identified new places r
The model's full reasoning — Q4 2016 call → NOWe need answer YES/NO based on transcript. Need determine if management describes currently in middle of copying a part of its own business that already works into additional places where same demand already visible. Need all three: proven instance, copies being stood up now, demand already identified at destination, and replication large relative to company, results reflect original. Let's parse transcript. Company has urology products: Urgent PC, Macroplastique, PrimeSight. They have sales organization. They are expanding into urogynecology and gynecology. Darin says: "we began to see the demand for our urology product lines extend to the related specialties of urogynecology and gynecology. And as a result of this development our Urgent PC sales plan during 2017 is to aggressively convert new customers from the urogyne and gyne segments, while we continue to focus on our core urology market." This is about expanding into additional customer segments. Is that "copying a part of its own business" - i.e., taking proven Urgent PC product and sales approach into new specialties? But are copies physically being stood up now? They mention "new sales resource is already onboard" for government accounts. They have sales force. But is there a specific proven instance being replicated? They have existing urology market success. They are targeting urogynecology and gynecology. Demand already visible? They say "we began to see the demand for our urology product lines extend to the related specialties" - that suggests demand already visible. But are they "standing up further instances" - like opening new offices, hiring sales reps for those segments? They added five urology sales heads over last several months. But is that copying a proven unit? The question asks: "does management convey that a specific, identifiable piece of the company has been proven out in real operation, and that the company is right now standing up further instances of that same piece in other locations, customers, markets, channels, applications, or lines, where management can already point to demand or commitment waiting for those new instances?" The transcript: They have proven Urgent PC in urology. They are expanding to urogynecology and gynecology. They have demand extending. But is this "copying" a piece? It's more like expanding sales focus to adjacent specialties.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| PUMP | ProPetro Holding Corp. | Q4 2023 | 2024-02-21 | C+ |
| BRBR | BellRing Brands, Inc. | Q4 2023 | 2023-11-21 | B+ |
| SYY | Sysco Corporation | Q1 2023 | 2022-11-01 | C+ |
| VSEC | VSE Corporation | Q3 2022 | 2022-10-28 | B+ |
| FSLR | First Solar, Inc. | Q3 2022 | 2022-10-28 | C+ |
| CRL | Charles River Laboratories International | Q2 2022 | 2022-08-03 | C |
| SYM | Symbotic Inc. | Q3 2022 | 2022-08-01 | B+ |
| GDS | GDS Holdings Limited | Q2 2021 | 2021-08-17 | C+ |
| TPIC | TPI Composites, Inc. | Q3 2018 | 2018-11-11 | C |
| ALB | Albemarle Corporation | Q3 2018 | 2018-11-08 | B |
| IRT | Independence Realty Trust, Inc. | Q2 2018 | 2018-08-02 | B |
| FOLD | Amicus Therapeutics, Inc. | Q1 2018 | 2018-05-08 | C+ |
| AOSL | Alpha and Omega Semiconductor Limited | Q2 2018 | 2018-02-07 | B |
| VSAT | Viasat, Inc. | Q4 2017 | 2017-05-23 | C+ |
| PLAB | Photronics, Inc. | Q2 2017 | 2017-05-17 | C+ |
| GOGO | Gogo Inc. | Q1 2016 | 2016-05-06 | C+ |
GDS · Q2 2021 → YESThe question is whether management describes the company as currently in the middle of copying a part of its own business that is already working into additional places where the same demand is alread...YES The transcript shows management describing a clear, present-tense replication of their proven China-based data center platform into new markets (Hong Kong, Macau, Southeast Asia) where demand is already visible and committed. William Huang explicitly references the “proven” China edge-of-town model (land-and-expand MOUs, 500 000 sqm secured pipeline, hyperscale orders already landed) and states they are “currently developing two purpose-built data centers” in Hong Kong (HK1/HK2) with most capacity “already allocated to strategic customers pending contracts,” plus a new building (HK4) under agreement and a heads-of-agreement for HK3, creating “nearly 80 megawatts of purpose-built capacity through to 2027.” For Macau they have a JV to acquire brownfield sites for redevelopment (20 MW).
FOLD · Q1 2018 → YESThe question is about whether management describes the company as currently copying a proven part of its business into additional places where demand is already visible. YES The transcript shows management describing Galafold as a proven commercial offering (Q1 revenue $16.7M, 300% YoY growth, hundreds of patients, high compliance, 7 approvals, 18 countries with pricing/reimbursement) that is now being replicated into additional markets.
TPIC · Q3 2018 → YESThe question is whether management describes the company as currently in the middle of copying a part of its own business that is already working into additional places where the same demand is alread...YES The transcript shows management describing a proven manufacturing operation (existing dedicated lines and plants in the U.S.